knowledge -WSS

knowledge

author：entertainment 2025-10-01 17:20:22 - browse：8

Microsoft's head of research Peter Lee speaking at STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is perhaps a testament to its potential — but it could also lead clinicians, and patients to experiment with it before there is wider consensus on how to navigate its biases and other pitfalls, Microsoft’s head of research Peter Lee said Thursday at STAT’s Breakthrough Summit.

About a month after OpenAI — Microsoft has a significant financial stake in the company — launched its chatbot in 2022 on November 30, which happened to be Lee’s birthday, he got a note from a doctor friend who said he’d used it so his receptionist could file after-visit summaries for patients. While Lee and a handful of other doctors at Microsoft had been impressed with the GPT-4’s capabilities, they knew it had weaknesses.

“The emotions were really mixed. I mean we were thrilled,” he said, but then “just within minutes there’s a feeling of dread. We had already come to the realization that GPT-4 would be prone to issues, issues of bias, hallucination, mathematical and logical errors,” he said. “And so, there’s an immediate question: ‘Should we allow this to happen?’”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： AstraZeneca loses challenge to Medicare drug price negotiation

leisure time

entertainment

WSS

Pumping milk in bathrooms at health conferences is common

The inclusion problem at the heart of rehabilitation research

RSV vaccines may be linked to small increased risk of developing GBS

How to address the problem of discarded donor organs

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Congress gives doctors Medicare pay bump

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

The high cost of giving birth even with insurance

AstraZeneca loses challenge to Medicare drug price negotiation

At least 13 dead in Texas as scorching temps continue

Pfizer highlights cancer drugs it thinks could reignite investor interest

Affirmative action in medical school literally saved lives

Medicare bonuses could stop drug shortages under Senate plan

Supreme Court strikes down use of affirmative action

Prior authorization reform is both possible and imperative

State Dept. review finds Biden bears some blame for Afghanistan failures

The inclusion problem at the heart of rehabilitation research

focus

House looks to weaken Medicare negotiation

Medicare bonuses could stop drug shortages under Senate plan

Covid isolation guidance eased by the CDC

Flu vaccine reformulation won't be easy, manufacturers warn

Flu vaccine offering decent levels of protection this winter, new data show

A Q&A with Aletha Maybank, AMA’s chief health equity officer

leisure time

leisure time

entertainment

focus